---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-071891"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:06:14.698508+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Eloxx shareholders elect all nine director nominees, ratify Deloitte, approve say-on-pay

## Summary
- 50,160,111 shares present (57.88% of outstanding) at June 15, 2022 annual meeting.
- All nine director nominees elected; votes for ranged from 21,179,908 to 25,579,083.
- Ratification of Deloitte as auditor: 49,488,639 for, 598,786 against.
- Advisory vote on executive compensation approved: 24,778,473 for, 1,082,703 against.
- Broker non-votes were 24,280,981 on director elections and say-on-pay.

## SEC filing metadata
- accession: 0001104659-22-071891
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465922071891/0001104659-22-071891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465922071891/tm2218608d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-071891
- JSON: https://secwatch.observer/filing/0001104659-22-071891.json
- Plain text: https://secwatch.observer/filing/0001104659-22-071891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.